About Us

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines. Our pipeline includes Bicycle® Toxin Conjugates as well as fully synthetic Bicycle systemic immune cell agonists and tumor-targeted immune cell agonists (Bicycle TICAs™) focused on oncology indications with high unmet medical need. Bicycle is headquartered in Cambridge, UK, and our US operations run out of Lexington, MA. Culture is key and all Bicycle employees actively embrace and role model our company values: • We are Adventurous. It’s the way to deliver extraordinary results for our patients. • We are Dedicated to our Mission. You can’t change the world if you don’t have determination. • We are One Team. We only succeed when we work together. Bicycle Therapeutics is committed to building a diverse workforce that is representative of the communities we serve. We recognize that diverse and inclusive teams build a stronger and more innovative company. Therefore, all qualified applicants will be considered for employment, and we do not discriminate on the basis of race, religion, color, gender, sexual orientation, age, disability status, marital status, or veteran status.